What is ferrous sulfate 325 mg
Searched over 200M research papers
Research Analysis by Consensus
Beta · 20 papersConsensus Meter
Yes%
Possibly%
No%
Understanding Ferrous Sulfate 325 mg: Uses, Efficacy, and Interactions
Introduction to Ferrous Sulfate 325 mg
Ferrous sulfate 325 mg is a commonly prescribed oral iron supplement used to treat iron deficiency anemia. It is often recommended for individuals who have low iron levels due to various conditions, including chronic kidney disease (CKD), postpartum anemia, and other forms of iron deficiency.
Efficacy in Treating Iron Deficiency Anemia
Chronic Kidney Disease (CKD) Patients
In patients with moderate to severe CKD, ferrous sulfate 325 mg has been compared to other iron supplements like ferric citrate. A study involving 60 adults with CKD and iron deficiency found that while both treatments improved iron parameters, ferric citrate resulted in a greater increase in transferrin saturation (TSAT) and ferritin levels compared to ferrous sulfate. This suggests that while ferrous sulfate is effective, other iron supplements may offer superior outcomes in certain populations.
Postpartum Anemia
For women with postpartum anemia, ferrous sulfate 325 mg has been evaluated against intravenous ferric carboxymaltose. The study concluded that ferric carboxymaltose was more effective in rapidly increasing hemoglobin levels and maintaining them over time. Additionally, it was associated with fewer drug-related adverse events compared to ferrous sulfate. This indicates that while ferrous sulfate is beneficial, intravenous options might be preferable for quicker and more sustained results.
Drug Interactions and Bioavailability
Interaction with Levodopa
Ferrous sulfate can significantly impact the bioavailability of other medications. For instance, when taken with levodopa, a common treatment for Parkinson's disease, ferrous sulfate reduced peak levodopa levels by 55% and the area under the curve (AUC) by 51%. This interaction is likely due to the chelation of iron by levodopa, which reduces the drug's absorption and efficacy.
Interaction with Methyldopa
Similarly, ferrous sulfate affects the absorption and metabolism of methyldopa, a medication used to manage hypertension. The presence of ferrous sulfate decreased the proportion of methyldopa absorbed and increased the proportion excreted as methyldopa sulfate, leading to reduced blood pressure control in patients. This highlights the importance of monitoring and possibly adjusting methyldopa dosages when co-administered with ferrous sulfate.
Interaction with Gemifloxacin
Ferrous sulfate also interacts with gemifloxacin, an antimicrobial agent. When gemifloxacin was taken three hours after ferrous sulfate, there was a modest reduction in its bioavailability, which was not deemed clinically significant. However, to avoid potential interactions, it is recommended to administer gemifloxacin at least two hours before or three hours after ferrous sulfate.
Conclusion
Ferrous sulfate 325 mg is an effective treatment for iron deficiency anemia, particularly in patients with CKD and postpartum anemia. However, its efficacy can be influenced by the presence of other medications due to significant drug interactions. These interactions can reduce the bioavailability and effectiveness of co-administered drugs, necessitating careful management and timing of doses. Understanding these interactions is crucial for optimizing treatment outcomes and ensuring patient safety.
Sources and full results
Most relevant research papers on this topic